Description
Thisguidance documentupdates and clarifies the information regarding sterilization processes that we recommend sponsors include in 510(k)s for devices labeled as sterile. This guidance document also provides details about the pyrogenicity information that we recommend sponsors include in a 510(k) submission. For the current edition of the FDA-recognized standards referenced in this document, see the FDA Recognized Consensus Standards Database Web site athttp://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm.
Key Topics
Terms and concepts identified from this document
Scope & Applicability
Product Classes
3Device category that may be exempt from certain UDI requirements if GMP exempt.
Device classification mentioned regarding novel sterilization methods
Devices intended for one use only
Stakeholders
1Entity responsible for submitting applications under section 524B
Regulatory Context
Regulatory Activities
3Premarket notification submission type
Premarket Approval Application
Humanitarian Device Exemption submissions; Humanitarian Device Exemption pathway
Document Types
2contains characterization of materials
the validation protocol; and the sterilization validation data
Attributes
2Premarket Submission Recommendations including Pyrogenicity
Quality parameter that must remain unchanged for the policy
Technical Details
Testing Methods
6Also known as the Limulus amebocyte lysate (LAL) test
associated seal strength testing, to validate package integrity
simulated (and/or real-time) aging and associated seal strength testing
description of the package test methods, but not package test data
the method used to validate the sterilization cycle (e.g., the half-cycle method)
FDA recommends that package test methods include simulated distribution
Processes
10Required for contaminated equipment and media before disposal
Established sterilization method; Established Category A sterilization method using a fixed, rigid chamber
Established sterilization method; Established Category A sterilization method
High-risk manufacturing area requiring specific gowning; Access to aseptic processing areas during inspection
Established Category A sterilization method
Example of a sterilization method.
Established Category A sterilization method including gamma or electron beam
Established Category B sterilization method
Novel sterilization method
information identified in Section V.A above, the sponsor should provide the following information in a 510(k) for all novel sterilization methods
Identified Hazards
Hazards
2Risk to human health from failure to assure sterility
chemicals leaching from device causing febrile reaction
Standards & References
External Standards
4Packaging for terminally sterilized medical devices, series of consensus standards
Viral Safety Evaluation of Biotechnology products derived from cell lines of human or animal origin
Medical Devices-Bacterial Endotoxin and Pyrogen Tests
Bacterial endotoxins – Test methods, routine monitoring, and alternatives
Related CFR Sections (5)
- 21CFR880.6860§ 880.6860 Ethylene oxide gas sterilizer.
(a) Identification. An ethylene gas sterilizer is a nonportable device intended for use by a health care provider that uses ethylene oxide (ETO) to sterilize medical products.Read full regulation →
- 21CFR880.6870§ 880.6870 Dry-heat sterilizer.
(a) Identification. A dry-heat sterilizer is a device that is intended for use by a health care provider to sterilize medical products by means of dry heat.Read full regulation →
- 21CFR880.6880§ 880.6880 Steam sterilizer.
(a) Identification. A steam sterilizer (autoclave) is a device that is intended for use by a health care provider to sterilize medical products by means of pressurized steam.Read full regulation →
- 21CFR880.6885§ 880.6885 Liquid chemical sterilants/high level disinfectants.
(a) Identification. A liquid chemical sterilant/high level disinfectant is a germicide that is intended for use as the terminal step in processing critical and semicritical medical devices prior to patient use. Critical devices make contact with normally sterile tissue or body spaces during use. SemRead full regulation →
- 21CFR876.1500§ 876.1500 Endoscope and accessories.
(a) Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optRead full regulation →
Enforcement Impact
Deficiencies cited in Warning Letters referencing the same regulations
Recent Cases
- 2026-02-24
CGMP/QSR/Medical Devices/Adulterated
Beta Bionics, Inc.
- 2025-12-09
CGMP/QSR/Medical Devices/Adulterated
Envoy Medical Inc.
- 2025-11-25
CGMP/QSR/Medical Devices/Adulterated
Hong Qiangxing Shenzhen Electronics Limited
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated
Contec Medical Systems Co., Ltd.
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Royal Philips
Related Warning Letters (10)
- 2026-02-24
CGMP/QSR/Medical Devices/Adulterated
Beta Bionics, Inc.
- 2025-12-09
CGMP/QSR/Medical Devices/Adulterated
Envoy Medical Inc.
- 2025-11-25
CGMP/QSR/Medical Devices/Adulterated
Hong Qiangxing Shenzhen Electronics Limited
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated
Contec Medical Systems Co., Ltd.
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Royal Philips
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Qianjiang Kingphar Medical Material Co Ltd.
- 2025-10-21
CGMP/QSR/Medical Devices/Adulterated
LEVO AG
- 2025-10-07
CGMP/QSR/Medical Devices/Adulterated
Technological Medical Advancements LLC
- 2025-09-23
Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)
The Richline Group, Inc.
- 2025-09-16
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
SeniorLife Technologies, Inc.
See Also (8)
- Content of Premarket Submissions for Device Software Functions: Guidance for Industry and Food and Drug Administration Staff (Status: Final)
- CPG Sec. 130.400 Use of Microfiche and/or Microfilm for Method of Records Retention (Status: Final)
- CPG Sec. 130.300 FDA Access to Results of Quality Assurance Program Audits and Inspections (Status: Final)
- CPG Sec. 300.100 Inspection of Manufacturers of Device Components (Status: Final)
- Device Labeling Guidance #G91-1 (Blue Book Memo) (Status: Final)
- CPG Sec. 310.100 Pacemaker Reuse (Status: Final)
- Variance from Manufacturer Report Number Format - No. 5 (Status: Final)
- Immunotoxicity Testing Guidance (Status: Final)